

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 9.97388352 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 9.97388352 |
| 3 | detection of temperature stimulus (GO:0016048) | 9.08724543 |
| 4 | negative regulation of dendrite morphogenesis (GO:0050774) | 8.68842216 |
| 5 | peripheral nervous system neuron development (GO:0048935) | 8.46846076 |
| 6 | neurofilament cytoskeleton organization (GO:0060052) | 7.34180578 |
| 7 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 7.07327000 |
| 8 | transcytosis (GO:0045056) | 6.68357948 |
| 9 | glycerolipid catabolic process (GO:0046503) | 6.53770946 |
| 10 | cell migration in hindbrain (GO:0021535) | 6.30143930 |
| 11 | lipid storage (GO:0019915) | 5.68284112 |
| 12 | diacylglycerol metabolic process (GO:0046339) | 5.58213934 |
| 13 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.56925688 |
| 14 | negative regulation of dendrite development (GO:2000171) | 5.52779209 |
| 15 | protein heterotrimerization (GO:0070208) | 5.41681644 |
| 16 | fatty acid homeostasis (GO:0055089) | 5.38773841 |
| 17 | NADH metabolic process (GO:0006734) | 5.27761463 |
| 18 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 5.21933570 |
| 19 | ovulation from ovarian follicle (GO:0001542) | 4.96601936 |
| 20 | negative regulation of granulocyte differentiation (GO:0030853) | 4.91991124 |
| 21 | lipid particle organization (GO:0034389) | 4.88076162 |
| 22 | neuronal action potential (GO:0019228) | 4.80506062 |
| 23 | polyol transport (GO:0015791) | 4.80000443 |
| 24 | regulation of cholesterol storage (GO:0010885) | 4.79198835 |
| 25 | white fat cell differentiation (GO:0050872) | 4.72459786 |
| 26 | ethanol oxidation (GO:0006069) | 4.61402435 |
| 27 | plasma lipoprotein particle clearance (GO:0034381) | 4.55680712 |
| 28 | positive regulation of lipid storage (GO:0010884) | 4.53085986 |
| 29 | brown fat cell differentiation (GO:0050873) | 4.50537024 |
| 30 | negative regulation of macrophage differentiation (GO:0045650) | 4.49135741 |
| 31 | cellular response to epinephrine stimulus (GO:0071872) | 4.46455136 |
| 32 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.38080184 |
| 33 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.37934926 |
| 34 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.36153511 |
| 35 | innervation (GO:0060384) | 4.30734523 |
| 36 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.30189567 |
| 37 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.28728982 |
| 38 | regulation of platelet aggregation (GO:0090330) | 4.28216230 |
| 39 | neuronal action potential propagation (GO:0019227) | 4.20276962 |
| 40 | negative regulation of amino acid transport (GO:0051956) | 4.19725502 |
| 41 | negative regulation of protein autophosphorylation (GO:0031953) | 4.19350365 |
| 42 | positive regulation of cholesterol efflux (GO:0010875) | 4.17593964 |
| 43 | triglyceride metabolic process (GO:0006641) | 4.17207927 |
| 44 | regulation of gonadotropin secretion (GO:0032276) | 4.16136236 |
| 45 | biotin metabolic process (GO:0006768) | 4.15467413 |
| 46 | triglyceride biosynthetic process (GO:0019432) | 4.10695494 |
| 47 | negative regulation of smooth muscle cell migration (GO:0014912) | 4.07167970 |
| 48 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.05635875 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.03977477 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.03977477 |
| 51 | membrane depolarization during action potential (GO:0086010) | 4.00634089 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 4.00099261 |
| 53 | proline transport (GO:0015824) | 3.98565199 |
| 54 | response to phenylpropanoid (GO:0080184) | 3.96171392 |
| 55 | establishment of mitochondrion localization (GO:0051654) | 3.93134466 |
| 56 | acylglycerol biosynthetic process (GO:0046463) | 3.89626356 |
| 57 | neutral lipid biosynthetic process (GO:0046460) | 3.89626356 |
| 58 | neuron fate specification (GO:0048665) | 3.89461435 |
| 59 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.89288058 |
| 60 | acylglycerol metabolic process (GO:0006639) | 3.86413230 |
| 61 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.82839829 |
| 62 | neutral lipid metabolic process (GO:0006638) | 3.80907080 |
| 63 | negative regulation of metanephros development (GO:0072217) | 3.80545478 |
| 64 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.80226003 |
| 65 | negative regulation of gluconeogenesis (GO:0045721) | 3.79273814 |
| 66 | cellular response to nicotine (GO:0071316) | 3.78492037 |
| 67 | response to water (GO:0009415) | 3.73828425 |
| 68 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.73740960 |
| 69 | mitochondrion transport along microtubule (GO:0047497) | 3.73740960 |
| 70 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.73423001 |
| 71 | positive regulation of glucose import (GO:0046326) | 3.73398209 |
| 72 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.71501301 |
| 73 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.67864566 |
| 74 | positive regulation of glycolytic process (GO:0045821) | 3.67556166 |
| 75 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.66568099 |
| 76 | oxaloacetate metabolic process (GO:0006107) | 3.64754120 |
| 77 | cranial nerve development (GO:0021545) | 3.64274414 |
| 78 | response to epinephrine (GO:0071871) | 3.64005209 |
| 79 | regulation of receptor binding (GO:1900120) | 3.62872559 |
| 80 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.59607781 |
| 81 | glomerular filtration (GO:0003094) | 3.59014184 |
| 82 | positive regulation of cholesterol transport (GO:0032376) | 3.57704845 |
| 83 | positive regulation of sterol transport (GO:0032373) | 3.57704845 |
| 84 | protein localization to cell surface (GO:0034394) | 3.51088111 |
| 85 | valine metabolic process (GO:0006573) | 3.50626994 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 3.49551825 |
| 87 | response to pain (GO:0048265) | 3.49106010 |
| 88 | regulation of lipoprotein metabolic process (GO:0050746) | 3.48304494 |
| 89 | ethanol metabolic process (GO:0006067) | 3.47874093 |
| 90 | response to acidic pH (GO:0010447) | 3.47232051 |
| 91 | cGMP-mediated signaling (GO:0019934) | 3.46741102 |
| 92 | behavioral response to pain (GO:0048266) | 3.45765814 |
| 93 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.44844324 |
| 94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44799420 |
| 95 | primary alcohol metabolic process (GO:0034308) | 3.44272385 |
| 96 | barbed-end actin filament capping (GO:0051016) | 3.43140552 |
| 97 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.43069229 |
| 98 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.42766929 |
| 99 | negative regulation of neurological system process (GO:0031645) | 3.40450090 |
| 100 | enteric nervous system development (GO:0048484) | 3.37915570 |
| 101 | regulation of lipid storage (GO:0010883) | 3.37356250 |
| 102 | cellular response to leptin stimulus (GO:0044320) | 3.34090939 |
| 103 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.33194741 |
| 104 | positive regulation of metanephros development (GO:0072216) | 3.29253960 |
| 105 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.28434819 |
| 106 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.27909631 |
| 107 | retinal ganglion cell axon guidance (GO:0031290) | 3.27675356 |
| 108 | phosphatidic acid biosynthetic process (GO:0006654) | 3.27305173 |
| 109 | phosphatidic acid metabolic process (GO:0046473) | 3.27305173 |
| 110 | triglyceride homeostasis (GO:0070328) | 3.26198594 |
| 111 | acylglycerol homeostasis (GO:0055090) | 3.26198594 |
| 112 | intermediate filament organization (GO:0045109) | 3.25617546 |
| 113 | inositol phosphate catabolic process (GO:0071545) | 3.25160860 |
| 114 | glycerol metabolic process (GO:0006071) | 3.24691524 |
| 115 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.23354147 |
| 116 | angiogenesis involved in wound healing (GO:0060055) | 3.22685355 |
| 117 | cellular response to vitamin (GO:0071295) | 3.22359751 |
| 118 | regulation of relaxation of muscle (GO:1901077) | 3.21064538 |
| 119 | cellular response to lithium ion (GO:0071285) | 3.20414884 |
| 120 | negative regulation of lipid catabolic process (GO:0050995) | 3.19868204 |
| 121 | renal filtration (GO:0097205) | 3.18632877 |
| 122 | positive regulation of glucose transport (GO:0010828) | 3.17686768 |
| 123 | response to vitamin E (GO:0033197) | 3.15940730 |
| 124 | negative regulation of response to food (GO:0032096) | 3.15563922 |
| 125 | negative regulation of appetite (GO:0032099) | 3.15563922 |
| 126 | negative regulation of smooth muscle contraction (GO:0045986) | 3.14320725 |
| 127 | regulation of glomerulus development (GO:0090192) | 3.13884411 |
| 128 | nerve growth factor signaling pathway (GO:0038180) | 3.13215820 |
| 129 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.12537339 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11662965 |
| 131 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.11401619 |
| 132 | negative regulation of platelet activation (GO:0010544) | 3.10635086 |
| 133 | triglyceride catabolic process (GO:0019433) | 3.10373362 |
| 134 | negative regulation of cation channel activity (GO:2001258) | 3.10342538 |
| 135 | endocrine hormone secretion (GO:0060986) | 3.09814963 |
| 136 | endothelium development (GO:0003158) | 3.09753145 |
| 137 | response to leptin (GO:0044321) | 3.09739943 |
| 138 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.09087108 |
| 139 | cell communication involved in cardiac conduction (GO:0086065) | 3.08486744 |
| 140 | carnitine shuttle (GO:0006853) | 3.06008496 |
| 141 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.99233769 |
| 142 | nerve development (GO:0021675) | 2.97005275 |
| 143 | regulation of cell communication by electrical coupling (GO:0010649) | 2.95239966 |
| 144 | axon development (GO:0061564) | 2.95060864 |
| 145 | fatty acid transmembrane transport (GO:1902001) | 2.94823387 |
| 146 | action potential (GO:0001508) | 2.94741518 |
| 147 | suckling behavior (GO:0001967) | 2.91614367 |
| 148 | acrosome reaction (GO:0007340) | 2.90001817 |
| 149 | potassium ion export (GO:0071435) | 2.88280864 |
| 150 | regulation of sequestering of triglyceride (GO:0010889) | 2.83160666 |
| 151 | regulation of protein heterodimerization activity (GO:0043497) | 2.79578187 |
| 152 | neutral lipid catabolic process (GO:0046461) | 2.77941608 |
| 153 | acylglycerol catabolic process (GO:0046464) | 2.77941608 |
| 154 | alanine transport (GO:0032328) | 2.77513821 |
| 155 | G-protein coupled receptor internalization (GO:0002031) | 2.77425026 |
| 156 | low-density lipoprotein particle clearance (GO:0034383) | 2.77324345 |
| 157 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.76491825 |
| 158 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.74281399 |
| 159 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.71725246 |
| 160 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.70538027 |
| 161 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.70160988 |
| 162 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.69029265 |
| 163 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.67436839 |
| 164 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.63782621 |
| 165 | intermediate filament-based process (GO:0045103) | 2.63190683 |
| 166 | activation of protein kinase A activity (GO:0034199) | 2.62058914 |
| 167 | membrane budding (GO:0006900) | 2.61096156 |
| 168 | positive regulation of axon extension (GO:0045773) | 2.60767762 |
| 169 | positive regulation of macrophage differentiation (GO:0045651) | 2.60752184 |
| 170 | mechanoreceptor differentiation (GO:0042490) | 2.60439439 |
| 171 | synaptic vesicle maturation (GO:0016188) | 2.58732822 |
| 172 | urinary tract smooth muscle contraction (GO:0014848) | 2.58732498 |
| 173 | intermediate filament cytoskeleton organization (GO:0045104) | 2.58105844 |
| 174 | regulation of cell maturation (GO:1903429) | 2.57908092 |
| 175 | response to dietary excess (GO:0002021) | 2.57811205 |
| 176 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.57295090 |
| 177 | regulation of protein kinase A signaling (GO:0010738) | 2.56304037 |
| 178 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.53145939 |
| 179 | negative regulation of bone resorption (GO:0045779) | 2.51821275 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.51004410 |
| 181 | axon cargo transport (GO:0008088) | 2.50996700 |
| 182 | organelle transport along microtubule (GO:0072384) | 2.50927870 |
| 183 | positive regulation of steroid hormone secretion (GO:2000833) | 2.50756484 |
| 184 | positive regulation of glomerulus development (GO:0090193) | 2.48605610 |
| 185 | activation of adenylate cyclase activity (GO:0007190) | 2.47962414 |
| 186 | serotonin receptor signaling pathway (GO:0007210) | 2.47159309 |
| 187 | negative regulation of membrane potential (GO:0045837) | 2.46975230 |
| 188 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.46971232 |
| 189 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.45383096 |
| 190 | sodium ion transmembrane transport (GO:0035725) | 2.44893457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00683953 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.38548970 |
| 3 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.38009896 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.78664101 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.77489671 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69982315 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.69933841 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67206958 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.57810915 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45696033 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43274810 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41627089 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40295785 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38131584 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38131584 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35248311 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.24192525 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.23275629 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.20950138 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17657054 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17609093 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.15130244 |
| 23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12055464 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.09950639 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.09929016 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08241178 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.07791805 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05969610 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00385028 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98634405 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.94630507 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93466104 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89467071 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87827839 |
| 35 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.85618667 |
| 36 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.83991245 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.82836066 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.80360887 |
| 39 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.80360887 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.77786334 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71310751 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69252013 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65215443 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.65047711 |
| 45 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64847237 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.64712251 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62901493 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.61003390 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60426132 |
| 50 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.58229765 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57777909 |
| 52 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.57720852 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56603311 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54468109 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51620470 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47959284 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46030594 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45864071 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43837732 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43039407 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.42840185 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39639266 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38153080 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36128764 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34998828 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34787469 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31819873 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31592660 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30154252 |
| 70 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28837046 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28573095 |
| 72 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26040590 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24786497 |
| 74 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.24382769 |
| 75 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23719304 |
| 76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23268568 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22995411 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21621399 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20329645 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18342766 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17564796 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16951811 |
| 83 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16768757 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16689082 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14933692 |
| 86 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.14761014 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13684581 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13117580 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.13033951 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12906047 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12906047 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12228005 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10970919 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10852190 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10257834 |
| 96 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10212487 |
| 97 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09054942 |
| 98 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.08324035 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07783385 |
| 100 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06697293 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06287365 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05237085 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05132472 |
| 104 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.04313755 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03433568 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03254826 |
| 107 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02174292 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02076581 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01094246 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01094246 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00454643 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99971990 |
| 113 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99446919 |
| 114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99012853 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96945159 |
| 116 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.96358239 |
| 117 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95556896 |
| 118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94013213 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93520814 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93348795 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 0.92982999 |
| 122 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.92650942 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92529608 |
| 124 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92376710 |
| 125 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91632815 |
| 126 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91632815 |
| 127 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91632815 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88926215 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88797688 |
| 130 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88427455 |
| 131 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88257645 |
| 132 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88048693 |
| 133 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87930891 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87619628 |
| 135 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87595520 |
| 136 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86714010 |
| 137 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86549555 |
| 138 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86313453 |
| 139 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.86172651 |
| 140 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85893078 |
| 141 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85180785 |
| 142 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84655988 |
| 143 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84358752 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84280468 |
| 145 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83892276 |
| 146 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83831453 |
| 147 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83703427 |
| 148 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83448256 |
| 149 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82860951 |
| 150 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81926589 |
| 151 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81580285 |
| 152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.79655390 |
| 153 | P68_20966046_ChIP-Seq_HELA_Human | 0.77477836 |
| 154 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77115890 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76115091 |
| 156 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75172593 |
| 157 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.73804945 |
| 158 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73594339 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72535915 |
| 160 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.71631948 |
| 161 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70849044 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70343798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 7.78297569 |
| 2 | MP0006276_abnormal_autonomic_nervous | 5.21732495 |
| 3 | MP0004270_analgesia | 4.91817987 |
| 4 | MP0001986_abnormal_taste_sensitivity | 4.87847521 |
| 5 | MP0001968_abnormal_touch/_nociception | 4.59128481 |
| 6 | MP0002736_abnormal_nociception_after | 4.28816913 |
| 7 | MP0004858_abnormal_nervous_system | 4.00278229 |
| 8 | MP0002733_abnormal_thermal_nociception | 3.51775011 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 3.44564414 |
| 10 | MP0004147_increased_porphyrin_level | 3.05294612 |
| 11 | MP0001970_abnormal_pain_threshold | 3.01584434 |
| 12 | MP0005670_abnormal_white_adipose | 2.78936041 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.51225466 |
| 14 | MP0006138_congestive_heart_failure | 2.49466744 |
| 15 | MP0003724_increased_susceptibility_to | 2.27841932 |
| 16 | MP0003828_pulmonary_edema | 2.27571669 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.25495539 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.17368697 |
| 19 | MP0001348_abnormal_lacrimal_gland | 2.16768425 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.14081842 |
| 21 | MP0002751_abnormal_autonomic_nervous | 2.11851012 |
| 22 | MP0004130_abnormal_muscle_cell | 1.98413873 |
| 23 | MP0002184_abnormal_innervation | 1.92946838 |
| 24 | MP0003186_abnormal_redox_activity | 1.85959714 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.82589088 |
| 26 | MP0003868_abnormal_feces_composition | 1.81471474 |
| 27 | MP0003011_delayed_dark_adaptation | 1.81390786 |
| 28 | MP0003690_abnormal_glial_cell | 1.80452937 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.80389411 |
| 30 | MP0002272_abnormal_nervous_system | 1.79692746 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.78098968 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.73730799 |
| 33 | MP0009046_muscle_twitch | 1.62013941 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.58649441 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.58229123 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.52735724 |
| 37 | MP0000343_altered_response_to | 1.52141759 |
| 38 | MP0003329_amyloid_beta_deposits | 1.44761278 |
| 39 | MP0005535_abnormal_body_temperature | 1.36906169 |
| 40 | MP0004272_abnormal_basement_membrane | 1.35284361 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.30984767 |
| 42 | MP0003279_aneurysm | 1.30923366 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.27623993 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.26839969 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.22759817 |
| 46 | MP0002295_abnormal_pulmonary_circulatio | 1.20194056 |
| 47 | MP0008260_abnormal_autophagy | 1.19653564 |
| 48 | MP0001188_hyperpigmentation | 1.19377460 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.14751878 |
| 50 | MP0002933_joint_inflammation | 1.13670540 |
| 51 | MP0000749_muscle_degeneration | 1.12555383 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.12482170 |
| 53 | MP0000955_abnormal_spinal_cord | 1.10644603 |
| 54 | MP0001270_distended_abdomen | 1.10110808 |
| 55 | MP0003880_abnormal_central_pattern | 1.09819032 |
| 56 | MP0005647_abnormal_sex_gland | 1.05852222 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.05368298 |
| 58 | MP0001542_abnormal_bone_strength | 1.05316619 |
| 59 | MP0003635_abnormal_synaptic_transmissio | 1.04770909 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.04612658 |
| 61 | MP0003646_muscle_fatigue | 1.03947904 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.03480704 |
| 63 | MP0001984_abnormal_olfaction | 1.03426751 |
| 64 | MP0000249_abnormal_blood_vessel | 1.03142343 |
| 65 | MP0008569_lethality_at_weaning | 1.02631714 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.01473969 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.00779913 |
| 68 | MP0003948_abnormal_gas_homeostasis | 0.99802849 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.99144241 |
| 70 | MP0002971_abnormal_brown_adipose | 0.98532678 |
| 71 | MP0001958_emphysema | 0.96799007 |
| 72 | MP0000751_myopathy | 0.96589917 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.96551435 |
| 74 | MP0004087_abnormal_muscle_fiber | 0.96052264 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.95131669 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.94139000 |
| 77 | MP0005164_abnormal_response_to | 0.94048422 |
| 78 | MP0004859_abnormal_synaptic_plasticity | 0.94012951 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.89909632 |
| 80 | MP0000604_amyloidosis | 0.88505935 |
| 81 | MP0001727_abnormal_embryo_implantation | 0.87725032 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.87313510 |
| 83 | MP0001881_abnormal_mammary_gland | 0.87191433 |
| 84 | MP0009115_abnormal_fat_cell | 0.85503066 |
| 85 | MP0005334_abnormal_fat_pad | 0.83949680 |
| 86 | MP0001764_abnormal_homeostasis | 0.83828780 |
| 87 | MP0002882_abnormal_neuron_morphology | 0.82546230 |
| 88 | MP0000858_altered_metastatic_potential | 0.81992978 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.81189893 |
| 90 | MP0009745_abnormal_behavioral_response | 0.80694036 |
| 91 | MP0002229_neurodegeneration | 0.80074369 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79869662 |
| 93 | MP0002009_preneoplasia | 0.77824012 |
| 94 | MP0000609_abnormal_liver_physiology | 0.77375065 |
| 95 | MP0002970_abnormal_white_adipose | 0.75060120 |
| 96 | MP0002063_abnormal_learning/memory/cond | 0.74873653 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.73948678 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.73542342 |
| 99 | MP0005448_abnormal_energy_balance | 0.72521197 |
| 100 | MP0002064_seizures | 0.72281330 |
| 101 | MP0004142_abnormal_muscle_tone | 0.71504249 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.70561446 |
| 103 | MP0003633_abnormal_nervous_system | 0.70297519 |
| 104 | MP0003634_abnormal_glial_cell | 0.70153418 |
| 105 | MP0002133_abnormal_respiratory_system | 0.69685770 |
| 106 | MP0005388_respiratory_system_phenotype | 0.69685770 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.69352992 |
| 108 | MP0004883_abnormal_blood_vessel | 0.68199382 |
| 109 | MP0002972_abnormal_cardiac_muscle | 0.67999829 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.67759799 |
| 111 | MP0003953_abnormal_hormone_level | 0.67639220 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.67150234 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.66629009 |
| 114 | MP0005275_abnormal_skin_tensile | 0.64873812 |
| 115 | MP0001919_abnormal_reproductive_system | 0.64441276 |
| 116 | MP0002066_abnormal_motor_capabilities/c | 0.64119231 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.63673562 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.63424943 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.63183242 |
| 120 | MP0004924_abnormal_behavior | 0.63183242 |
| 121 | MP0002572_abnormal_emotion/affect_behav | 0.62988294 |
| 122 | MP0005409_darkened_coat_color | 0.62966566 |
| 123 | MP0004085_abnormal_heartbeat | 0.62851675 |
| 124 | MP0003879_abnormal_hair_cell | 0.62801362 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.61321419 |
| 126 | MP0003959_abnormal_lean_body | 0.60726189 |
| 127 | MP0005508_abnormal_skeleton_morphology | 0.59486773 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.59090946 |
| 129 | MP0003075_altered_response_to | 0.59036634 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.58786641 |
| 131 | MP0003045_fibrosis | 0.58528790 |
| 132 | MP0005365_abnormal_bile_salt | 0.58244752 |
| 133 | MP0002796_impaired_skin_barrier | 0.57850459 |
| 134 | MP0001661_extended_life_span | 0.56864759 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.56603563 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.56603563 |
| 137 | MP0002160_abnormal_reproductive_system | 0.55465774 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.55385289 |
| 139 | MP0008874_decreased_physiological_sensi | 0.55231440 |
| 140 | MP0002060_abnormal_skin_morphology | 0.54981158 |
| 141 | MP0001486_abnormal_startle_reflex | 0.54585815 |
| 142 | MP0004036_abnormal_muscle_relaxation | 0.54409521 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.53699115 |
| 144 | MP0009643_abnormal_urine_homeostasis | 0.53379403 |
| 145 | MP0003448_altered_tumor_morphology | 0.52222730 |
| 146 | MP0000778_abnormal_nervous_system | 0.50821040 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.50748851 |
| 148 | MP0005452_abnormal_adipose_tissue | 0.50542597 |
| 149 | MP0005620_abnormal_muscle_contractility | 0.50187220 |
| 150 | MP0002166_altered_tumor_susceptibility | 0.49981123 |
| 151 | MP0001944_abnormal_pancreas_morphology | 0.48744735 |
| 152 | MP0001177_atelectasis | 0.48449739 |
| 153 | MP0003091_abnormal_cell_migration | 0.48095420 |
| 154 | MP0005369_muscle_phenotype | 0.48044277 |
| 155 | MP0005266_abnormal_metabolism | 0.47296108 |
| 156 | MP0001614_abnormal_blood_vessel | 0.47082562 |
| 157 | MP0001545_abnormal_hematopoietic_system | 0.47038609 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.47038609 |
| 159 | MP0001533_abnormal_skeleton_physiology | 0.46506835 |
| 160 | MP0002128_abnormal_blood_circulation | 0.46161567 |
| 161 | MP0005165_increased_susceptibility_to | 0.45868804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 7.73369601 |
| 2 | Action tremor (HP:0002345) | 6.87074373 |
| 3 | Myokymia (HP:0002411) | 5.72148382 |
| 4 | Hypothermia (HP:0002045) | 5.71498514 |
| 5 | Increased variability in muscle fiber diameter (HP:0003557) | 5.20008240 |
| 6 | Protrusio acetabuli (HP:0003179) | 5.17586028 |
| 7 | Abnormality of pain sensation (HP:0010832) | 5.11333177 |
| 8 | Impaired pain sensation (HP:0007328) | 5.11333177 |
| 9 | Dysautonomia (HP:0002459) | 4.96847725 |
| 10 | Insulin resistance (HP:0000855) | 4.84576938 |
| 11 | Termporal pattern (HP:0011008) | 4.58991125 |
| 12 | Insidious onset (HP:0003587) | 4.58991125 |
| 13 | Pheochromocytoma (HP:0002666) | 4.50436310 |
| 14 | Difficulty running (HP:0009046) | 4.49794194 |
| 15 | Oligomenorrhea (HP:0000876) | 4.46224517 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.36433975 |
| 17 | Neuroendocrine neoplasm (HP:0100634) | 4.27950356 |
| 18 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.04376677 |
| 19 | Autoamputation (HP:0001218) | 3.88483675 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.85866122 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.82351834 |
| 22 | Myocardial infarction (HP:0001658) | 3.79836966 |
| 23 | Bradycardia (HP:0001662) | 3.72834689 |
| 24 | Febrile seizures (HP:0002373) | 3.70349830 |
| 25 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.69233408 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.64819772 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.64016805 |
| 28 | Bone cyst (HP:0012062) | 3.62950892 |
| 29 | Spinal rigidity (HP:0003306) | 3.56522896 |
| 30 | Steppage gait (HP:0003376) | 3.56515193 |
| 31 | Atonic seizures (HP:0010819) | 3.51284140 |
| 32 | Hypercortisolism (HP:0001578) | 3.51131451 |
| 33 | Complement deficiency (HP:0004431) | 3.48983654 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 3.40864364 |
| 35 | Foot dorsiflexor weakness (HP:0009027) | 3.39306739 |
| 36 | Aortic aneurysm (HP:0004942) | 3.29647741 |
| 37 | Skin nodule (HP:0200036) | 3.26588889 |
| 38 | Hammertoe (HP:0001765) | 3.24796620 |
| 39 | Long foot (HP:0001833) | 3.19826082 |
| 40 | Arthropathy (HP:0003040) | 3.19473175 |
| 41 | Vertebral compression fractures (HP:0002953) | 3.16933874 |
| 42 | Thyroid carcinoma (HP:0002890) | 3.13433115 |
| 43 | Abnormality of complement system (HP:0005339) | 3.13254161 |
| 44 | Ectopia lentis (HP:0001083) | 3.07960314 |
| 45 | Colitis (HP:0002583) | 3.07625951 |
| 46 | Distal arthrogryposis (HP:0005684) | 3.05881647 |
| 47 | Epidermoid cyst (HP:0200040) | 3.05596428 |
| 48 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.04195550 |
| 49 | Back pain (HP:0003418) | 3.03776381 |
| 50 | Myotonia (HP:0002486) | 3.03667862 |
| 51 | Polycythemia (HP:0001901) | 3.03055616 |
| 52 | Axonal loss (HP:0003447) | 3.01818976 |
| 53 | Abnormality of the foot musculature (HP:0001436) | 2.95032950 |
| 54 | Submucous cleft hard palate (HP:0000176) | 2.87622976 |
| 55 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.85965468 |
| 56 | Areflexia of lower limbs (HP:0002522) | 2.84815145 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.82641251 |
| 58 | Striae distensae (HP:0001065) | 2.82620003 |
| 59 | Growth hormone excess (HP:0000845) | 2.81019956 |
| 60 | Amyloidosis (HP:0011034) | 2.79224680 |
| 61 | Prominent supraorbital ridges (HP:0000336) | 2.78141251 |
| 62 | Subcapsular cataract (HP:0000523) | 2.77610361 |
| 63 | Failure to thrive in infancy (HP:0001531) | 2.77230413 |
| 64 | Cervical subluxation (HP:0003308) | 2.73231332 |
| 65 | Lymphangioma (HP:0100764) | 2.67573404 |
| 66 | Cerebral aneurysm (HP:0004944) | 2.66977227 |
| 67 | Nausea (HP:0002018) | 2.66850053 |
| 68 | Abnormality of the vocal cords (HP:0008777) | 2.66222804 |
| 69 | Shallow orbits (HP:0000586) | 2.66060293 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.61675109 |
| 71 | Ileus (HP:0002595) | 2.59305417 |
| 72 | Focal motor seizures (HP:0011153) | 2.57124936 |
| 73 | Broad metatarsal (HP:0001783) | 2.56167373 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.54372772 |
| 75 | Distal sensory impairment (HP:0002936) | 2.53963826 |
| 76 | Focal seizures (HP:0007359) | 2.52945690 |
| 77 | Polyphagia (HP:0002591) | 2.52821065 |
| 78 | Decreased motor nerve conduction velocity (HP:0003431) | 2.52024843 |
| 79 | Progressive cerebellar ataxia (HP:0002073) | 2.51990645 |
| 80 | Polar cataract (HP:0010696) | 2.51895074 |
| 81 | Neck muscle weakness (HP:0000467) | 2.51665737 |
| 82 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.50472254 |
| 83 | Frequent falls (HP:0002359) | 2.48442242 |
| 84 | Acanthosis nigricans (HP:0000956) | 2.48426811 |
| 85 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.48105075 |
| 86 | Lipoatrophy (HP:0100578) | 2.48104390 |
| 87 | Abnormal hemoglobin (HP:0011902) | 2.44359452 |
| 88 | Palpitations (HP:0001962) | 2.44089519 |
| 89 | Accelerated skeletal maturation (HP:0005616) | 2.43188396 |
| 90 | Xanthomatosis (HP:0000991) | 2.42787839 |
| 91 | Episodic fever (HP:0001954) | 2.42441842 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40890227 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 2.38878825 |
| 94 | Vascular tortuosity (HP:0004948) | 2.36156800 |
| 95 | Thoracolumbar scoliosis (HP:0002944) | 2.35005057 |
| 96 | Onion bulb formation (HP:0003383) | 2.32967276 |
| 97 | Ankle contracture (HP:0006466) | 2.32130241 |
| 98 | Recurrent corneal erosions (HP:0000495) | 2.30347318 |
| 99 | Fasciculations (HP:0002380) | 2.27669312 |
| 100 | Ankle clonus (HP:0011448) | 2.26041826 |
| 101 | Menstrual irregularities (HP:0000858) | 2.25808953 |
| 102 | Wormian bones (HP:0002645) | 2.25428731 |
| 103 | Orthostatic hypotension (HP:0001278) | 2.22415499 |
| 104 | Infantile muscular hypotonia (HP:0008947) | 2.21318100 |
| 105 | Easy fatigability (HP:0003388) | 2.21232719 |
| 106 | Delusions (HP:0000746) | 2.18244928 |
| 107 | Stridor (HP:0010307) | 2.18039868 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.17780170 |
| 109 | Mitral valve prolapse (HP:0001634) | 2.17273536 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 2.14592610 |
| 111 | Dilatation of the ascending aorta (HP:0005111) | 2.13795829 |
| 112 | Cerebral hemorrhage (HP:0001342) | 2.13365944 |
| 113 | Gowers sign (HP:0003391) | 2.09914932 |
| 114 | Pulmonary artery stenosis (HP:0004415) | 2.09867832 |
| 115 | Spastic gait (HP:0002064) | 2.06836842 |
| 116 | Hyperglycinuria (HP:0003108) | 2.03805253 |
| 117 | Abnormal eating behavior (HP:0100738) | 2.03457922 |
| 118 | Abnormality of the corticospinal tract (HP:0002492) | 2.01705721 |
| 119 | Esophageal varix (HP:0002040) | 2.01573995 |
| 120 | Large hands (HP:0001176) | 2.00953093 |
| 121 | Hepatic necrosis (HP:0002605) | 2.00629329 |
| 122 | Venous abnormality (HP:0002624) | 1.99794406 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.98627132 |
| 124 | Joint hemorrhage (HP:0005261) | 1.97956194 |
| 125 | Muscle stiffness (HP:0003552) | 1.96845708 |
| 126 | Decreased muscle mass (HP:0003199) | 1.95069641 |
| 127 | Absence seizures (HP:0002121) | 1.94703433 |
| 128 | Apathy (HP:0000741) | 1.94663753 |
| 129 | Urinary urgency (HP:0000012) | 1.94221411 |
| 130 | Glucose intolerance (HP:0000833) | 1.93960117 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93501795 |
| 132 | Lower limb muscle weakness (HP:0007340) | 1.92118682 |
| 133 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91247734 |
| 134 | Hypoplasia of the brainstem (HP:0002365) | 1.91247734 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.90224015 |
| 136 | Scanning speech (HP:0002168) | 1.89808262 |
| 137 | Increased serum pyruvate (HP:0003542) | 1.89355521 |
| 138 | Mutism (HP:0002300) | 1.87510360 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.87483621 |
| 140 | Diminished motivation (HP:0000745) | 1.87425703 |
| 141 | Abnormality of the periventricular white matter (HP:0002518) | 1.86631750 |
| 142 | Prolonged bleeding time (HP:0003010) | 1.86490824 |
| 143 | Knee flexion contracture (HP:0006380) | 1.85755374 |
| 144 | Gastrointestinal dysmotility (HP:0002579) | 1.85668309 |
| 145 | Hepatocellular necrosis (HP:0001404) | 1.85321247 |
| 146 | Impaired proprioception (HP:0010831) | 1.84647173 |
| 147 | Short tibia (HP:0005736) | 1.83636589 |
| 148 | Ventricular fibrillation (HP:0001663) | 1.83492937 |
| 149 | Muscle fibrillation (HP:0010546) | 1.82833831 |
| 150 | Increased muscle lipid content (HP:0009058) | 1.82042481 |
| 151 | Delayed gross motor development (HP:0002194) | 1.82024852 |
| 152 | Hypoventilation (HP:0002791) | 1.81899754 |
| 153 | Soft skin (HP:0000977) | 1.80950988 |
| 154 | Arterial tortuosity (HP:0005116) | 1.80338335 |
| 155 | Obstructive sleep apnea (HP:0002870) | 1.79810871 |
| 156 | Aortic valve stenosis (HP:0001650) | 1.79329604 |
| 157 | Abnormality of dental color (HP:0011073) | 1.79216304 |
| 158 | Hypoalphalipoproteinemia (HP:0003233) | 1.79175327 |
| 159 | Atrioventricular block (HP:0001678) | 1.79109441 |
| 160 | Overgrowth (HP:0001548) | 1.78857692 |
| 161 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.77902372 |
| 162 | Myoglobinuria (HP:0002913) | 1.76219225 |
| 163 | Aneurysm (HP:0002617) | 1.75797110 |
| 164 | Dialeptic seizures (HP:0011146) | 1.75755188 |
| 165 | Truncal ataxia (HP:0002078) | 1.74721629 |
| 166 | Aortic dissection (HP:0002647) | 1.74601622 |
| 167 | Anosmia (HP:0000458) | 1.73109070 |
| 168 | Hypoplasia of the iris (HP:0007676) | 1.73077412 |
| 169 | Anxiety (HP:0000739) | 1.72947897 |
| 170 | Nuclear cataract (HP:0100018) | 1.72813432 |
| 171 | Megalocornea (HP:0000485) | 1.72782287 |
| 172 | Increased mean platelet volume (HP:0011877) | 1.72490918 |
| 173 | Generalized tonic-clonic seizures (HP:0002069) | 1.72434655 |
| 174 | Depression (HP:0000716) | 1.72116785 |
| 175 | Venous insufficiency (HP:0005293) | 1.71796036 |
| 176 | Bulbar palsy (HP:0001283) | 1.71080865 |
| 177 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70957055 |
| 178 | Curly hair (HP:0002212) | 1.70355199 |
| 179 | Increased connective tissue (HP:0009025) | 1.68778674 |
| 180 | Retinal dysplasia (HP:0007973) | 1.68378890 |
| 181 | Abnormality of glycolysis (HP:0004366) | 1.66401702 |
| 182 | Emphysema (HP:0002097) | 1.66031133 |
| 183 | Metaphyseal dysplasia (HP:0100255) | 1.65594817 |
| 184 | Polygenic inheritance (HP:0010982) | 1.65447802 |
| 185 | Spinal cord lesions (HP:0100561) | 1.64869677 |
| 186 | Aqueductal stenosis (HP:0002410) | 1.64348136 |
| 187 | Neonatal onset (HP:0003623) | 1.63728945 |
| 188 | Chin dimple (HP:0010751) | 1.63715438 |
| 189 | Emotional lability (HP:0000712) | 1.63040859 |
| 190 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.62218603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 5.40169846 |
| 2 | TIE1 | 4.20218355 |
| 3 | CASK | 4.08553831 |
| 4 | EPHB2 | 3.77138697 |
| 5 | LMTK2 | 3.71866764 |
| 6 | MATK | 3.61053866 |
| 7 | RIPK1 | 3.55688916 |
| 8 | DDR2 | 3.47657394 |
| 9 | MINK1 | 3.43274247 |
| 10 | TGFBR2 | 3.34224530 |
| 11 | NTRK3 | 3.03214776 |
| 12 | PRKAA2 | 3.01747286 |
| 13 | MAPKAPK3 | 2.97464899 |
| 14 | CAMK1 | 2.56537190 |
| 15 | TESK1 | 2.49451955 |
| 16 | SIK3 | 2.40048069 |
| 17 | MAP3K6 | 2.39873363 |
| 18 | SIK1 | 2.35116980 |
| 19 | ERN1 | 2.29954621 |
| 20 | SGK2 | 2.04885871 |
| 21 | KSR2 | 2.02174032 |
| 22 | MAP3K12 | 2.01207094 |
| 23 | PDGFRA | 1.94847236 |
| 24 | SCYL2 | 1.88207707 |
| 25 | EEF2K | 1.88147191 |
| 26 | LIMK1 | 1.81714481 |
| 27 | MAPK4 | 1.80009972 |
| 28 | MAPK13 | 1.78506145 |
| 29 | EPHA3 | 1.77161099 |
| 30 | SGK494 | 1.75596407 |
| 31 | SGK223 | 1.75596407 |
| 32 | ABL2 | 1.70729624 |
| 33 | MAP2K1 | 1.68903788 |
| 34 | NEK9 | 1.66494312 |
| 35 | MAP3K13 | 1.62277732 |
| 36 | MAP3K2 | 1.58394087 |
| 37 | GRK5 | 1.52406266 |
| 38 | PHKG1 | 1.51145743 |
| 39 | PHKG2 | 1.51145743 |
| 40 | ARAF | 1.50431206 |
| 41 | LATS1 | 1.47297946 |
| 42 | FER | 1.43697216 |
| 43 | CSK | 1.43519492 |
| 44 | RIPK4 | 1.42762753 |
| 45 | RPS6KA2 | 1.41946194 |
| 46 | RET | 1.41640653 |
| 47 | CAMKK2 | 1.38800150 |
| 48 | CDK6 | 1.37942774 |
| 49 | LATS2 | 1.37715245 |
| 50 | SGK3 | 1.36227618 |
| 51 | MAPK12 | 1.30467153 |
| 52 | CAMK1D | 1.30084798 |
| 53 | MAP2K4 | 1.27375743 |
| 54 | MOS | 1.24816376 |
| 55 | YES1 | 1.20509059 |
| 56 | MAP3K9 | 1.19676625 |
| 57 | MAP2K7 | 1.16869255 |
| 58 | FGFR3 | 1.15033028 |
| 59 | PDK3 | 1.08021074 |
| 60 | PDK4 | 1.08021074 |
| 61 | FES | 1.07851157 |
| 62 | KDR | 1.05750817 |
| 63 | PRPF4B | 1.03162751 |
| 64 | PDGFRB | 1.01539873 |
| 65 | PINK1 | 1.01295700 |
| 66 | PRKCH | 1.01036435 |
| 67 | KIT | 0.97319956 |
| 68 | PRKG2 | 0.91542307 |
| 69 | MAP3K4 | 0.88430309 |
| 70 | BCKDK | 0.87696562 |
| 71 | WNK1 | 0.86582967 |
| 72 | BCR | 0.85831051 |
| 73 | MAPK7 | 0.85245940 |
| 74 | TNK2 | 0.84018477 |
| 75 | NLK | 0.83649585 |
| 76 | JAK2 | 0.79878376 |
| 77 | GSK3A | 0.79753928 |
| 78 | TYK2 | 0.79719729 |
| 79 | ADRBK1 | 0.76955976 |
| 80 | CAMK1G | 0.76486632 |
| 81 | CDC42BPA | 0.75736333 |
| 82 | PKN1 | 0.75697623 |
| 83 | DYRK2 | 0.73827163 |
| 84 | PRKG1 | 0.73386665 |
| 85 | PAK2 | 0.71843483 |
| 86 | MAP3K1 | 0.70030545 |
| 87 | CDK9 | 0.69907871 |
| 88 | FRK | 0.69654425 |
| 89 | PDPK1 | 0.69137407 |
| 90 | ILK | 0.68339367 |
| 91 | PKN2 | 0.66625999 |
| 92 | CDK4 | 0.65858805 |
| 93 | PTK2 | 0.65573419 |
| 94 | PRKCG | 0.64526985 |
| 95 | TRIB3 | 0.64332583 |
| 96 | CDK5 | 0.63543085 |
| 97 | PAK6 | 0.63440841 |
| 98 | DAPK2 | 0.62887836 |
| 99 | MAP3K11 | 0.62392606 |
| 100 | PDK1 | 0.59418419 |
| 101 | JAK3 | 0.59091169 |
| 102 | ADRBK2 | 0.58869955 |
| 103 | RPS6KB1 | 0.58815198 |
| 104 | STK24 | 0.58473994 |
| 105 | MARK2 | 0.58371008 |
| 106 | MAPK3 | 0.57101692 |
| 107 | PRKACB | 0.54962927 |
| 108 | MARK3 | 0.54634711 |
| 109 | PRKD1 | 0.54036019 |
| 110 | MTOR | 0.52460205 |
| 111 | TYRO3 | 0.52138563 |
| 112 | PRKCE | 0.51476339 |
| 113 | MAP3K7 | 0.51471774 |
| 114 | CAMKK1 | 0.50686871 |
| 115 | PRKD3 | 0.49939102 |
| 116 | PRKACG | 0.49390415 |
| 117 | FGFR4 | 0.48986653 |
| 118 | GRK1 | 0.45699722 |
| 119 | STK39 | 0.45641933 |
| 120 | MAP2K6 | 0.44769724 |
| 121 | PAK4 | 0.44670222 |
| 122 | BRAF | 0.44261387 |
| 123 | RPS6KC1 | 0.43622990 |
| 124 | RPS6KL1 | 0.43622990 |
| 125 | TBK1 | 0.43494130 |
| 126 | TTN | 0.43313572 |
| 127 | CDK14 | 0.42466842 |
| 128 | ABL1 | 0.42409542 |
| 129 | RPS6KA3 | 0.41428453 |
| 130 | STK38L | 0.41077604 |
| 131 | IRAK1 | 0.40350142 |
| 132 | MST1R | 0.39781125 |
| 133 | KSR1 | 0.39229418 |
| 134 | INSR | 0.38121286 |
| 135 | AKT2 | 0.38093635 |
| 136 | STK38 | 0.37701686 |
| 137 | PRKD2 | 0.37606708 |
| 138 | PIM2 | 0.36745398 |
| 139 | CAMK2G | 0.36498213 |
| 140 | SRC | 0.36360900 |
| 141 | WNK4 | 0.35873663 |
| 142 | HIPK2 | 0.35610819 |
| 143 | MAP2K2 | 0.35275840 |
| 144 | ERBB2 | 0.35127505 |
| 145 | DAPK3 | 0.34784235 |
| 146 | MARK1 | 0.34403991 |
| 147 | PRKACA | 0.34160385 |
| 148 | MAPK1 | 0.34000826 |
| 149 | MAPKAPK5 | 0.33938848 |
| 150 | AURKA | 0.33446498 |
| 151 | DMPK | 0.32422572 |
| 152 | RPS6KA6 | 0.32126488 |
| 153 | IGF1R | 0.32124426 |
| 154 | EPHB1 | 0.30733268 |
| 155 | PRKAA1 | 0.30609701 |
| 156 | ZAP70 | 0.30168892 |
| 157 | MAP2K3 | 0.30130907 |
| 158 | PDK2 | 0.29253958 |
| 159 | TRPM7 | 0.28963618 |
| 160 | IRAK2 | 0.28168687 |
| 161 | AKT3 | 0.27788868 |
| 162 | GRK7 | 0.27311433 |
| 163 | JAK1 | 0.27064679 |
| 164 | MUSK | 0.25637155 |
| 165 | ROCK1 | 0.24195314 |
| 166 | MYLK | 0.23997782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.63701556 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.37857677 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.94206459 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53829112 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.50623455 |
| 6 | Thyroid cancer_Homo sapiens_hsa05216 | 2.41483709 |
| 7 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.39922879 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.37718688 |
| 9 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.33958875 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23109080 |
| 11 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.22715913 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21021086 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.20753443 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12834772 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.10077826 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92516285 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83202373 |
| 18 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.73683741 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.68316278 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.66092980 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62449358 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60850503 |
| 23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.58845408 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58616303 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58268041 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57108903 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.56067835 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45127070 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.44062163 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41736734 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.38555701 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.37289014 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31479407 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24661502 |
| 35 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21969645 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.05982250 |
| 37 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05732849 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.03593142 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01957700 |
| 40 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00839089 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00755068 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00664407 |
| 43 | Melanoma_Homo sapiens_hsa05218 | 1.00453609 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.00027527 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 0.99601746 |
| 46 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99288674 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98737663 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94680424 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94316645 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94148030 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93425794 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91032757 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.90251251 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90099867 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86108319 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86064417 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85561834 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85014765 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84945094 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84107147 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83251719 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.83228237 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82569974 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82014796 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80574134 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.80344108 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79288577 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79096053 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78601560 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.78592265 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78432300 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77159051 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76032554 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75532176 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.75262981 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74031763 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73220522 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72510029 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71391072 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70725206 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69932942 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69783603 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68688700 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66458554 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66151129 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.65996776 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65730953 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65617496 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64068154 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63073596 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63031826 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62467965 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62305936 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61942909 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.61690055 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61104614 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.60999418 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60873056 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60803579 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60758549 |
| 101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60027358 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59358439 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58081385 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55428166 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.54968254 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54553703 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54476152 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54473916 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.53977290 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53412216 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53003520 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51364883 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51225074 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49689532 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47792520 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45438119 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45213413 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44872744 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44455785 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44387257 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42850795 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42815681 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41965792 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40749200 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38408307 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37899529 |
| 127 | Phototransduction_Homo sapiens_hsa04744 | 0.37403958 |
| 128 | Long-term depression_Homo sapiens_hsa04730 | 0.37241042 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37120182 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36514477 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36171737 |
| 132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34836474 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33991570 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32770969 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.31566218 |
| 136 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29126199 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28881228 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.28303844 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27120572 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.26725189 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26027963 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.25842969 |
| 143 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24409553 |
| 144 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23496595 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21416741 |
| 146 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18899676 |
| 147 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16744941 |
| 148 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16541107 |
| 149 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.16523160 |
| 150 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15701189 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15430201 |
| 152 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15179746 |
| 153 | Axon guidance_Homo sapiens_hsa04360 | 0.15091063 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14943282 |
| 155 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.14343735 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.14246231 |
| 157 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13672732 |

